Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Sees Large Drop in Short Interest

Posted by on Jun 29th, 2026

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY – Get Free Report) saw a large decline in short interest during the month of June. As of June 15th, there was short interest totaling 15,401 shares, a decline of 79.5% from the May 31st total of 74,992 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily volume of 457,076 shares, the short-interest ratio is presently 0.0 days.

Shionogi & Co., Ltd. Unsponsored ADR Trading Up 0.7%

Shares of OTCMKTS SGIOY traded up $0.06 during mid-day trading on Monday, hitting $8.58. 151,097 shares of the company traded hands, compared to its average volume of 133,788. The company has a quick ratio of 1.46, a current ratio of 1.58 and a debt-to-equity ratio of 0.01. Shionogi & Co., Ltd. Unsponsored ADR has a 1 year low of $7.65 and a 1 year high of $12.00. The stock has a market capitalization of $14.60 billion, a price-to-earnings ratio of 10.73, a PEG ratio of 3.31 and a beta of 0.08. The business has a 50 day moving average of $9.30 and a two-hundred day moving average of $9.90.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY – Get Free Report) last issued its quarterly earnings results on Tuesday, May 12th. The company reported $0.18 earnings per share for the quarter, topping analysts’ consensus estimates of $0.15 by $0.03. Shionogi & Co., Ltd. Unsponsored ADR had a return on equity of 13.56% and a net margin of 41.08%.The firm had revenue of $881.71 million for the quarter, compared to analysts’ expectations of $895.52 million. On average, sell-side analysts anticipate that Shionogi & Co., Ltd. Unsponsored ADR will post 0.8 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the stock. Zacks Research upgraded shares of Shionogi & Co., Ltd. Unsponsored ADR from a “strong sell” rating to a “hold” rating in a report on Monday, May 25th. The Goldman Sachs Group raised Shionogi & Co., Ltd. Unsponsored ADR from a “hold” rating to a “strong-buy” rating in a report on Monday, June 15th. One investment analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy”.

View Our Latest Stock Analysis on SGIOY

Shionogi & Co., Ltd. Unsponsored ADR Company Profile

(Get Free Report)

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.

Featured Articles

Receive News & Ratings for Shionogi & Co. Ltd. Unsponsored ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shionogi & Co. Ltd. Unsponsored ADR and related companies with MarketBeat.com's FREE daily email newsletter.